Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosine-protein kinase Tie-2 is an endothelial-specific receptor tyrosine kinase encoded by the *TEK* gene. Located at the endothelial cell surface, Tie-2 binds the angiopoietins (primarily angiopoietin-1 and angiopoietin-2), which regulate its activation. Ligand engagement induces Tie2 dimerization and clustering, leading to autophosphorylation and activation of intracellular signaling cascades essential for blood vessel maturation, stabilization, and maintenance of vascular integrity. Dysregulation of Tie-2 signaling contributes to pathologies such as tumor angiogenesis, inflammatory vascular leakage, and primary congenital glaucoma. Therapeutic targeting of Tie-2 focuses on modulating angiopoietin binding or blocking its kinase activity to influence vascular remodeling in disease contexts[1][3][6][8].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine-protein kinase Tie-2 (Tie2).